Celgene Announces Will Offer Findings from Long-Term Post-Hoc Analysis of Pooled Data from PALACE Phase III Trial of Otezla at EULAR
June 09, 2015 at 18:02 PM EDT
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the findings from a ...